Katsuhito Fujiu

Katsuhito Fujiu

Auto-generated profile, based on publicly available information

Katsuhito Fujiu

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJunichi Sugita
Junichi Sugita
KFKatsuhito Fujiu
Katsuhito Fujiu
YNYukiteru Nakayama
Yukiteru Nakayama
TMTakumi Matsubara
Takumi Matsubara
JMJun Matsuda
Jun Matsuda
IKIssei Komuro
Issei Komuro
Cardiac arrhythmias are a primary contributor to sudden cardiac death, a major unmet medical need. Because right ventricular (RV) dysfunction increases the risk for sudden cardiac death, we examined responses to RV stress in mice. Among immune cells accumulated in the RV after pressure overload-induced by pulmonary artery banding, interfering with macrophages caused sudden death from severe arrhythmias. We show that cardiac macrophages crucially maintain cardiac impulse conduction by facilitating myocardial intercellular communication through gap junctions. Amphiregulin (AREG) produced by cardiac macrophages is a key mediator that controls connexin 43 phosphorylation and translocation in cardiomyocytes. Deletion of Areg from macrophages led to disorganization of gap junctions and, in turn, lethal arrhythmias during acute stresses, including RV pressure overload and β-adrenergic receptor stimulation. These results suggest that AREG from cardiac resident macrophages is a critical regulator of cardiac impulse conduction and may be a useful therapeutic target for the prevention of sudden death.

9 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMasahiro Shiozawa
Masahiro Shiozawa
Hidehiro KanekoHidehiro Kaneko
Hidehiro Kaneko
HIHidetaka Itoh
Hidetaka Itoh
KMKojiro Morita
Kojiro Morita
AOAkira Okada
Akira Okada
IKIssei Komuro
Issei Komuro
Data on the association between body mass index (BMI) and stroke are scarce. We aimed to examine the association between BMI and incident stroke (ischemic or hemorrhagic) and to clarify the relationship between underweight, overweight, and obesity and stroke risk stratified by sex. We analyzed the JMDC Claims Database between January 2005 and April 2020 including 2,740,778 healthy individuals (Median (interquartile) age, 45 (38–53) years; 56.2% men; median (interquartile) BMI, 22.3 (20.2–24.8) kg/m2). None of the participants had a history of cardiovascular disease. Each participant was categorized as underweight (BMI <18.5 kg/m2), normal weight (BMI 18.5–24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2), or obese (BMI ≥ 30 kg/m2). We investigated the association of BMI with incidence stroke in men and women using the Cox regression model. We used restricted cubic spline (RCS) functions to identify the association of BMI as a continuous parameter with incident stroke. The incidence (95% confidence interval) of total stroke, ischemic stroke, and hemorrhagic stroke was 32.5 (32.0–32.9), 28.1 (27.6–28.5), and 5.5 (5.3–5.7) per 10,000 person-years in men, whereas 25.7 (25.1–26.2), 22.5 (22.0–23.0), and 4.0 (3.8–4.2) per 10,000 person-years in women, respectively. Multivariable Cox regression analysis showed that overweight and obesity were associated with a higher incidence of total and ischemic stroke in both men and women. Underweight, overweight, and obesity were associated with a higher hemorrhagic stroke incidence in men, but not in women. Restricted cubic spline showed that the risk of ischemic stroke increased in a BMI dose-dependent manner in both men and women, whereas there was a U-shaped relationship between BMI and the hemorrhagic stroke risk in men. In conclusion, overweight and obesity were associated with a greater incidence of stroke and ischemic stroke in both men and women. Furthermore, underweight, overweight, and obesity were associated with a higher hemorrhagic stroke risk in men. Our results would help in the risk stratification of future stroke based on BMI.

1 May 2014 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
KFKatsuhito Fujiu
Katsuhito Fujiu
RNRyozo Nagai
Ryozo Nagai

6 June 2013 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
KFKatsuhito Fujiu
Katsuhito Fujiu
RNRyozo Nagai
Ryozo Nagai

9 December 2022 in Communications Medicine
Verified
Journal Article
Open access
PDF file
HIHirotaka Ieki
Hirotaka Ieki
KIKaoru Ito
Kaoru Ito
MSMike Saji
Mike Saji
RKRei Kawakami
Rei Kawakami
Yuji NagatomoYuji Nagatomo
Yuji Nagatomo
IKIssei Komuro
Issei Komuro
Background: In recent years, there has been considerable research on the use of artificial intelligence to estimate age and disease status from medical images. However, age estimation from chest X-ray (CXR) images has not been well studied and the clinical significance of estimated age has not been fully determined. Methods: To address this, we trained a deep neural network (DNN) model using more than 100,000 CXRs to estimate the patients’ age solely from CXRs. We applied our DNN to CXRs of 1562 consecutive hospitalized heart failure patients, and 3586 patients admitted to the intensive care unit with cardiovascular disease. Results: The DNN’s estimated age (X-ray age) showed a strong significant correlation with chronological age on the hold-out test data and independent test data. Elevated X-ray age is associated with worse clinical outcomes (heart failure readmission and all-cause death) for heart failure. Additionally, elevated X-ray age was associated with a worse prognosis in 3586 patients admitted to the intensive care unit with cardiovascular disease. Conclusions: Our results suggest that X-ray age can serve as a useful indicator of cardiovascular abnormalities, which will help clinicians to predict, prevent and manage cardiovascular diseases.

24 May 2024 in Science Immunology
Verified
Journal Article
Closed access
YNYukiteru Nakayama
Yukiteru Nakayama
KFKatsuhito Fujiu
Katsuhito Fujiu
TOTsukasa Oshima
Tsukasa Oshima
JMJun Matsuda
Jun Matsuda
JSJunichi Sugita
Junichi Sugita
IKIssei Komuro
Issei Komuro
Patients with heart failure (HF) often experience repeated acute decompensation and develop comorbidities such as chronic kidney disease and frailty syndrome. Although this suggests pathological interaction among comorbidities, the mechanisms linking them are poorly understood. Here, we identified alterations in hematopoietic stem cells (HSCs) as a critical driver of recurrent HF and associated comorbidities. Bone marrow transplantation from HF-experienced mice resulted in spontaneous cardiac dysfunction and fibrosis in recipient mice, as well as increased vulnerability to kidney and skeletal muscle insults. HF enhanced the capacity of HSCs to generate proinflammatory macrophages. In HF mice, global chromatin accessibility analysis and single-cell RNA-seq showed that transforming growth factor–β (TGF-β) signaling was suppressed in HSCs, which corresponded with repressed sympathetic nervous activity in bone marrow. Transplantation of bone marrow from mice in which TGF-β signaling was inhibited similarly exacerbated cardiac dysfunction. Collectively, these results suggest that cardiac stress modulates the epigenome of HSCs, which in turn alters their capacity to generate cardiac macrophage subpopulations. This change in HSCs may be a common driver of repeated HF events and comorbidity by serving as a key carrier of “stress memory.”